Clinical Trials in Maryland

Showing 5761-5780 of 23,284 trials

Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder

NCT05053503

The primary objective of this trial is to determine whether tAN can improve relapse prevention beyond that seen with extended-release injectable naltrexone during Phase II.

Opioid-use DisorderOpioid Withdrawal

Spark Biomedical, Inc.108 participantsStarted May 2022

Rancho Mirage, California, United States • Crownsville, Maryland, United States • Center City, Minnesota, United States +1 more locations

Active Not RecruitingPhase 1/212 miles

An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias

NCT05757570

The goal of this clinical study is to evaluate povetacicept in adults with autoimmune cytopenias of immune thrombocytopenia, autoimmune hemolytic anemia, and cold agglutinin disease to determine if povetacicept is safe and potentially beneficial in treating these diseases. During the study treatment period participants will receive povetacicept approximately every 4 weeks for 6 months, with the possibility of participating in a 6-month study treatment extension period.

Immune ThrombocytopeniaIdiopathic Thrombocytopenic PurpuraWarm Autoimmune Hemolytic Anemia+1 more

Alpine Immune Sciences, Inc.30 participantsStarted Jul 2023

Los Angeles, California, United States • Washington D.C., District of Columbia, United States • Cooper City, Florida, United States +41 more locations

Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder

An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias

Find Trials by Condition in Maryland

Task-dependent Effects of TMS on the Neural Biomarkers of Episodic Memory

Developing a Method to Objectively Measure Opioid Analgesia

Clinical Study of CMP-001 in Combination With Pembrolizumab or as a Monotherapy

Effects of Sleep Disruption on Drug Response

Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

Genetic and Environmental Risk Factors for Hemorrhagic Stroke

Behavioral Activation, Nutrition, and Activity Intervention

ROSE-Longitudinal Assessment With Neuroimaging

Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3)

Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL

Pilot Study of an NTproBNP Guided Strategy of Cardioprotection

Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households

Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population

Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy

DOAC in Unusual Site Venous Thrombosis

Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study

Predicting Local and Distant Recurrence in T1 Colorectal Cancer

Stage II/III Colorectal Cancer Recurrence